Key Metrics of Waters Corporation
Revenue$3.0B▼ 0.5% YoYFY 2023
Operating income$818M▼ 6.4% YoY
Net profit$642M▼ 9.3% YoY
Shareholders' equity$1.2B
Market cap$45.5BWAT · $462.72
About Waters Corporation
Company details
- Website
- waters.com
- Founded
- 1995
- Listed
- NYSE: WAT (since 1995)
Company summary
Legal nameWaters Corporation
TickerWAT
ExchangeNYSE
CountryUnited States
SEC CIK0001000697
Listed since1995
IndustryBiotechnology: Laboratory Analytical Instruments
SectorOther Industries · Discovered Companies
Websitehttp://www.waters.com
US market & SEC filings
WAT · NYSE · SEC CIK 0001000697
Last price · 02 Nov 2026
$462.72
−3.61%
Market cap$45.5B
P/E42.7On FY 2023 diluted EPS
Volume1,342,328
SectorIndustrialsBiotechnology: Laboratory Analytical Instruments
Country · IPOUnited StatesListed 1995
WAT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeShanghai
GSTIN—
Email—
Websitehttp://www.waters.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Similar companies
S
Seer, IncOther Industries
Same segment: Pharmaceuticals Life Sciences
T
TG TherapeuticsOther Industries
Same segment: Pharmaceuticals Life Sciences
C
Cryo-Cell InternationalOther Industries
Same segment: Pharmaceuticals Life Sciences
T
Travere TherapeuticsOther Industries
Same segment: Pharmaceuticals Life Sciences
K
Kodiak Sciences Inc.Other Industries
Same segment: Pharmaceuticals Life Sciences
T
Teledyne Oldham SimtronicsOther Industries
Same segment: Other Industries
C
CytokineticsOther Industries
Same segment: Pharmaceuticals Life Sciences
N
Nucana (United Kingdom)Other Industries
Same segment: Pharmaceuticals Life Sciences
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
manufacturing of scientific and technical instrumentation
Filings
No filings on record yet.